UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Franklin Street Advisors Inc. NC

Franklin Street Advisors Inc. NC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.9% in the second quarter, Holdings Channel reports. The firm owned 2,216 shares of the healthcare conglomerate’s stock after selling 67 shares during the quarter. Franklin Street Advisors Inc. NC’s holdings in UnitedHealth Group were worth $1,138,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. GSA Capital Partners LLP acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $642,000. Rowland & Co. Investment Counsel ADV acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $169,000. Unigestion Holding SA lifted its stake in shares of UnitedHealth Group by 25.9% in the 4th quarter. Unigestion Holding SA now owns 4,786 shares of the healthcare conglomerate’s stock worth $2,403,000 after acquiring an additional 986 shares during the period. IHT Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 9.9% in the 4th quarter. IHT Wealth Management LLC now owns 3,837 shares of the healthcare conglomerate’s stock worth $1,927,000 after acquiring an additional 345 shares during the period. Finally, Banco de Sabadell S.A lifted its stake in shares of UnitedHealth Group by 43.1% in the fourth quarter. Banco de Sabadell S.A now owns 10,402 shares of the healthcare conglomerate’s stock valued at $5,235,000 after purchasing an additional 3,132 shares during the period. Institutional investors and hedge funds own 87.25% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $517.46 on Friday. The company’s 50 day simple moving average is $530.11 and its 200 day simple moving average is $512.45. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The stock has a market capitalization of $484.02 billion, a PE ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same period last year, the company earned $4.70 earnings per share. The company’s quarterly revenue was up 12.6% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were given a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio (DPR) is 34.46%.

Analyst Ratings Changes

Several analysts recently commented on the stock. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Loop Capital began coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 price objective for the company. Raymond James raised their target price on shares of UnitedHealth Group from $620.00 to $635.00 in a report on Thursday. BMO Capital Markets raised their target price on shares of UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a report on Thursday, September 8th. Three investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $586.40.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the transaction, the director now directly owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. Insiders have sold a total of 139,051 shares of company stock valued at $74,450,958 over the last ninety days. Corporate insiders own 0.40% of the company’s stock.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.